Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Radiol Med ; 124(12): 1262-1269, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31583557

ABSTRACT

PURPOSE: To present our experience of cases of primary pulmonary lymphoma (PPL) found between January 2002 and July 2018, focusing on the radiological features and the differential diagnosis in order to contribute to the difficult role of the radiologist in the disease identification and to help the clinicians to reach the diagnosis. MATERIALS AND METHODS: CT scans of 30 patients (14 men and 16 women, aged 58-86, mean age 72 years) with PPL were retrospectively reviewed. All patients had a histopathological confirmation of the disease: MALT lymphoma (23 patients, 76.6%); diffuse large B-cell lymphoma-DLBCL (seven patients, 23.4%). All the staging CT scans were evaluated by three experienced radiologists dedicated to thoracic disease in order to radiologically define the predominant pattern of presentation. RESULTS: The following parenchymal patterns were observed: 11 patients with single/multiple nodules, five with masses/mass-like consolidations, 14 with consolidations with air bronchogram, 16 with ground-glass opacity, ten with angiogram sign, 22 with perilymphatic and/or peribronchovascular spread, 15 with associated lymphadenopathies, and 13 with pleural/chest wall involvement. The main characteristics of PPLs were the presence of consolidations and ground-glass opacities, with perilymphatic and/or bronchovascular spread. CONCLUSION: All the characteristics of the work should alert the radiologist to consider lymphoma among the possible differential diagnoses, always correlating the results of the CT examination with appropriate clinical laboratory evaluations.


Subject(s)
Lung Neoplasms/diagnostic imaging , Lymphoma, B-Cell, Marginal Zone/diagnostic imaging , Lymphoma, Large B-Cell, Diffuse/diagnostic imaging , Tomography, X-Ray Computed/methods , Aged , Aged, 80 and over , Diagnosis, Differential , Female , Humans , Lung/pathology , Lung Neoplasms/pathology , Lymphadenopathy/diagnostic imaging , Lymphoma, B-Cell, Marginal Zone/pathology , Lymphoma, Large B-Cell, Diffuse/pathology , Male , Middle Aged , Pleural Neoplasms/diagnostic imaging , Retrospective Studies
2.
World J Nucl Med ; 17(3): 157-165, 2018.
Article in English | MEDLINE | ID: mdl-30034279

ABSTRACT

Primary bone lymphoma (PBL) is a rare disease. Little is reported about response evaluation procedures in these patients. Our aim was to evaluate response to therapy according to fluorodeoxyglucose-positron emission tomography (FDG-PET) results, and in particular to test the Deauville 5-point scale as compared to the visual evaluation of FDG-PET scans in PBL. In this single-center study, we diagnosed 31 consecutive patients with PBL, of which 24 were evaluated with end-of-treatment FDG-PET. Patients' ages ranged from 19 to 82 years. Six patients were treated with chemotherapy, 24 with chemotherapy and radiotherapy, and one patient with radiotherapy alone. Six patients were affected by a pathological fracture. Four patients died within the range of 3 to 36 months after diagnosis. The average follow-up of the remaining patients was 70 (24-173) months. Overall survival was 87% at 5 years. The only positive prognostic factor was complete remission after chemotherapy. According to visual criteria, end-of-treatment FDG-PET was evaluated in 24 patients and it was positive in 11 (46%) and negative in 13 patients. We organized a retrospective central-blinded revision of end-of-therapy FDG-PET scans using the 5-point Deauville Score (DS). We reviewed 17 out of 24 patients and obtained the following results: at the end of therapy, 12 patients with DS score 2, three patients with DS score 3, one patient with DS score 4, and none with DS score 5. Considering that all the 24 patients achieved complete remission after treatment, visual interpretation produced 11/24 false-positive results, and DS interpretation produced 1/17 false-positive results, thus significantly reducing the number of false positives. In PBL, the final evaluation at the end of therapy with FDG-PET should be evaluated using Deauville 5-point scale in order to significantly reduce the risk of false-positive scans.

3.
Ann Ist Super Sanita ; 48(3): 319-27, 2012.
Article in English | MEDLINE | ID: mdl-23007057

ABSTRACT

INTRODUCTION: Vitamin D deficiency (VDD) is a common condition among several populations in the world. VDD is associated with higher incidence of immune system disorders and faster progression of some infectious diseases. Vitamin D is known to be of physiological importance, it is considered an essential micronutrient for the bone health and plays a beneficial role in the prevention and/or treatment of a number of chronic diseases. Vitamin D has a complex action on the immune system. RESULTS: Evidence that vitamin D protects against tuberculosis has been supported by in vitro, epidemiological and some preliminary clinical studies. Vitamin D has a potential effect on HIV (human immunodeficiency virus) and plays a crucial role in the defence against respiratory infections. CONCLUSIONS: Vitamin D supplementation could be a low-cost, practical method to protect groups of people with high incidence of those diseases. Public health education should stress the need for adequate dietary intake of vitamin D in those vulnerable groups.


Subject(s)
Infection Control/methods , Tuberculosis/prevention & control , Vitamin D/therapeutic use , Vitamins/therapeutic use , Dietary Supplements , HIV Infections/complications , Humans , Immune System/physiology , Respiratory Tract Infections/prevention & control , Vitamin D/metabolism , Vitamin D/physiology , Vitamin D Deficiency/complications , Vitamin D Deficiency/epidemiology , Vitamins/metabolism , Vitamins/physiology
4.
Ann Ist Super Sanita ; 47(4): 465-73, 2011.
Article in English | MEDLINE | ID: mdl-22194081

ABSTRACT

Worldly data show the increasing incidence of Mycobacterium tuberculosis (MTB) and particularly of multi-drug resistant tuberculosis (MDR-TB). In developing countries, TB control programmes are overwhelmed by the complexity of treating MDR-TB infected people, as current tools and therapies are inadequate. MDR-TB could become the main form of TB. Risk factors that make South Africa into one of the main epicentres are analysed. A review of the studies carried out about antitubercular properties of Allium sativum both in vitro and in vivo is provided. The researches about the garlic extracts effectiveness against clinical isolates of MDR-TB are of scientific importance. Allium sativum offers a hope for developing alternative drugs. The involvement of traditional healers (TH) in the TB health management could facilitate the administration of garlic extracts to the infected patients.


Subject(s)
Antitubercular Agents/therapeutic use , Garlic , Tuberculosis, Multidrug-Resistant/drug therapy , Developing Countries , Drug Resistance, Multiple, Bacterial , Humans , Pandemics , Plant Extracts/therapeutic use , Risk Factors , South Africa/epidemiology , Tuberculosis, Multidrug-Resistant/epidemiology
5.
Ann Ist Super Sanita ; 46(4): 349-59, 2010.
Article in English | MEDLINE | ID: mdl-21169666

ABSTRACT

In developing countries, it would be advisable to give priority to human immunodeficiency virus (HIV) prevention strategies, because of the high mortality caused by the rapid spread of the pandemic. Furthermore, HIV prevention could contribute to the mitigation of tuberculosis (TB) propagation, which is tightly correlated to acquired immune deficiency syndrome (AIDS). As demonstrated, male circumcision (MC) confers protection against HIV and sexually transmitted diseases (STD). The suggested strategy considers the neonatal MC advantageous, since it is safer, feasible, culturally more acceptable and less costly than adult MC. This approach is based on the assumption that, if newborn males are circumcised, within the next 15-20 years the sexually active population will be almost entirely circumcised and, consequently, the HIV transmission will be reduced. The employment of retrained traditional birth attendants is considered in order to implement the MC after the child birth and to facilitate its acceptance in those contexts where it is not traditionally performed.


Subject(s)
Circumcision, Male , HIV Infections/prevention & control , Midwifery , Sexually Transmitted Diseases/prevention & control , Drug Resistance , Health Policy , Humans , Infant, Newborn , Male , Religion , Tuberculosis/prevention & control , United Nations
6.
Mycoses ; 51(4): 354-6, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18855847

ABSTRACT

Here we describe a rare case of pulmonary mucormycosis and simultaneous cervical lymphadenitis in a patient with acute myeloid leukaemia. The patient was successfully treated with liposomal amphotericin B. The diagnosis of Mucor is very difficult, especially in severely immunocompromised patients. This report seems to be the first case about documented lymph node involvement by mucormycosis in humans.


Subject(s)
Leukemia, Myeloid, Acute/complications , Lung Diseases, Fungal/microbiology , Lymphadenitis/microbiology , Mucormycosis/diagnosis , Adult , Amphotericin B/therapeutic use , Humans , Lung Diseases, Fungal/drug therapy , Lymphadenitis/drug therapy , Male , Mucormycosis/drug therapy , Neck/pathology
7.
Oncol Rep ; 14(5): 1209-14, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16211287

ABSTRACT

In patients with Hodgkin's lymphoma (HL) at the end of first line therapy an accurate imaging technique with high prognostic value is needed to assess response to treatment and predict those patients who will suffer disease relapse. This technique and its results permit the quick initiation of a second line therapy in patients suffering from a progressive disease or those unresponsive to treatment avoid over-treatment of patients in complete remission or those having a non-active residual disease. We included a (18)FDG-positron emission tomography (PET) scan to the diagnostic set-up to investigate 28 patients following the end of their treatment. Fifteen patients out of the 28 (54%) had positive CT scans while 13 (46%) had negative ones. Eleven patients out of the 15 CT positive (73%) had negative PET scans and no relapse. The remaining four patients (27%) had positive PET scans with only one relapse (25%). With respect to the 13 patients who had negative CT scans, 9 patients (69%) had negative PET scans and no relapse. The remaining 4 patients (31%) had positive PET scans with 3 relapse cases (75%). In our final assessment after a median follow-up period of 45 months, starting from PET execution to the last follow-up, overall sensitivity of the CT and the PET were 25 and 100% respectively, specificity 42 and 83% respectively, positive predictive value (PPV) 7 and 50% respectively, negative predictive value (NPV) 77 and 100% respectively, and accuracy 39 and 86% respectively. In our experience, FDG-PET performed in patients after induction therapy appears to offer important additional information: FDG-PET results are predictors of prognosis giving 100% DFS in PET negative patients and 54% DSF in PET positive patients.


Subject(s)
Hodgkin Disease/diagnostic imaging , Positron-Emission Tomography , Adolescent , Adult , Aged , Female , Fluorodeoxyglucose F18 , Hodgkin Disease/drug therapy , Humans , Male , Middle Aged , Neoplasm, Residual , Predictive Value of Tests , Prognosis , Radiopharmaceuticals , Sensitivity and Specificity , Tomography, X-Ray Computed
8.
Leuk Lymphoma ; 44(11): 2015-8, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14738158

ABSTRACT

We report the case of a 31-year-old man with anaplastic large-cell lymphoma successfully treated with chemotherapy who showed mediastinal widening 5 months after autologous stem-cell transplantation. CT scan and PET evaluations were consistent with the diagnosis of benign thymic hyperplasia. Because of the rapid and aggressive course of this type of lymphoma, and the progressive widening of the mass at CT scan, we performed a mediastinal biopsy that confirmed these findings, showing normal thymic tissue. This is the first case of benign thymic hyperplasia defined with FDG-PET and confirmed by histologic evaluation.


Subject(s)
Carcinoma/therapy , Lymphoma, Non-Hodgkin/therapy , Peripheral Blood Stem Cell Transplantation/adverse effects , Thymus Hyperplasia/etiology , Tomography, Emission-Computed/methods , Adult , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma/complications , Fluorine Radioisotopes , Fluorodeoxyglucose F18 , Humans , Lymphoma, Non-Hodgkin/complications , Male , Radiopharmaceuticals , Thymus Hyperplasia/diagnostic imaging , Thymus Hyperplasia/pathology , Transplantation, Autologous
SELECTION OF CITATIONS
SEARCH DETAIL
...